Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination

被引:1
|
作者
Arnason, Niels Arni [1 ,2 ]
Johannsson, Freyr [3 ]
Landro, Ragna [1 ]
Hardarsson, Bjorn [1 ]
Gudmundsson, Sveinn [1 ]
Lian, Aina-Mari [4 ]
Reseland, Janne [4 ]
Rolfsson, Ottar [3 ]
Sigurjonsson, Olafur E. [1 ,2 ]
机构
[1] Landspitali Natl Univ Hosp Iceland, Blood Bank, IS-105 Reykjavik, Iceland
[2] Reykjavik Univ, Sch Engn, IS-105 Reykjavik, Iceland
[3] Univ Iceland, Dept Med, IS-105 Reykjavik, Iceland
[4] Univ Oslo, Fac Dent, Inst Clin Dent, N-0317 Oslo, Norway
来源
PATHOGENS | 2022年 / 11卷 / 03期
关键词
platelet concentrates; pathogen inactivation; proteins; cytokines; chemokines; growth factors; platelet storage lesion; SOLUBLE CD40 LIGAND; IN-VITRO ASSESSMENT; STORAGE LESION; BUFFY-COAT; BACTERIAL-CONTAMINATION; ACTIVE HAEMOVIGILANCE; TRANSFUSION REACTIONS; BLOOD COMPONENTS; PSORALEN; FEBRILE;
D O I
10.3390/pathogens11030350
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Platelet granules contain a diverse group of proteins. Upon activation and during storage, platelets release a number of proteins into the circulation or supernatant of stored platelet concentrate (PC). The aim of this work was to investigate the effect of pathogen inactivation (PI) on a selection of proteins released in stored platelets. Materials and Methods: PCs in platelet additive solution (PAS) were produced from whole blood donations using the buffy coat (BC) method. PCs in the treatment arm were pathogen inactivated with amotosalen and UVA, while PCs in the second arm were used as an untreated platelet control. Concentrations of 36 proteins were monitored in the PCs during storage. Results: The majority of proteins increased in concentration over the storage period. In addition, 10 of the 29 proteins that showed change had significantly different concentrations between the PI treatment and the control at one or more timepoints. A subset of six proteins displayed a PI-related drop in concentration. Conclusions: PI has limited effect on protein concentration stored PC supernatant. The protein's changes related to PI treatment with elevated concentration implicate accelerated Platelet storage lesion (PSL); in contrast, there are potential novel benefits to PI related decrease in protein concentration that need further investigation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] THE USE OF TACSI® SYSTEM: EFFECT OF AUTOMATION ON ROUTINE PRODUCTION OF POOLED PLATELET CONCENTRATES FOR PATHOGEN INACTIVATION IN A FRENCH REGIONAL BLOOD CENTER
    Isola, H.
    Kientz, D.
    Wiesel, M. L.
    Laforet, M.
    Cazenave, J. P.
    [J]. VOX SANGUINIS, 2010, 99 : 212 - 213
  • [42] Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates
    van der Meer, P. F.
    Gravemann, U.
    de Korte, D.
    Sumian, C.
    Tolksdorf, F.
    Mueller, T. H.
    Seltsam, A.
    [J]. VOX SANGUINIS, 2016, 111 (02) : 127 - 134
  • [43] Metabolomic profiling highlights oxidative damages in platelet concentrates treated for pathogen inactivation and shows protective role of urate
    Abonnenc, Melanie
    Crettaz, David
    Marvin, Laure
    Grund, Baptiste
    Sonego, Giona
    Bardyn, Manon
    Tissot, Jean-Daniel
    Prudent, Michel
    Rochat, Bertrand
    Lion, Niels
    [J]. METABOLOMICS, 2016, 12 (12)
  • [44] Metabolomic profiling highlights oxidative damages in platelet concentrates treated for pathogen inactivation and shows protective role of urate
    Mélanie Abonnenc
    David Crettaz
    Laure Marvin
    Baptiste Grund
    Giona Sonego
    Manon Bardyn
    Jean-Daniel Tissot
    Michel Prudent
    Bertrand Rochat
    Niels Lion
    [J]. Metabolomics, 2016, 12
  • [45] Recovery and life span of 111indium-radiolabelled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light
    Snyder, E
    Raife, T
    Lin, L
    Cimino, G
    Metzel, P
    Rheinschmidt, M
    Baril, L
    Davis, K
    Buchholz, DH
    Corash, L
    Conlan, MG
    [J]. TRANSFUSION, 2004, 44 (12) : 1732 - 1740
  • [46] In vitro evaluation of Haemonetics MCS plus apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set
    Isola, H
    Kientz, D
    Aleil, B
    Laeuffer, P
    Weil, J
    Wiesel, ML
    Laforêt, M
    Lin, L
    Mayaudon, V
    Cazenave, JP
    [J]. VOX SANGUINIS, 2006, 90 (02) : 128 - 130
  • [47] VALIDATION OF POOLED BUFFY COAT PLATELET COMPONENTS SUSPENDED IN A MIXTURE OF PLASMA AND SSP plus TREATED WITH INTERCEPT™ PATHOGEN INACTIVATION AT CENTER FOR TRANSFUSION SERVICES (CTS) IN LUXEMBOURG
    Malvaux, N.
    Courrier, P.
    Collard, M.
    [J]. VOX SANGUINIS, 2010, 99 : 253 - 253
  • [48] Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light
    Hindawi, S., I
    El-Kafrawy, S. A.
    Hassan, A. M.
    Badawi, M. A.
    Bayoumi, M. M.
    Almalki, A. A.
    Zowawi, H. M.
    Tolah, A. M.
    Alandijany, T. A.
    Abunada, Q.
    Picard-Maureau, M.
    Damanhouri, G. A.
    Azhar, E., I
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2022, 29 (01) : 31 - 36
  • [49] Safety Profile of Platelet Components Treated with Amotosalen-UVA Pathogen Inactivation Transfused in Routine Use: Multi-Year Active Hemovigilance.
    Corash, Laurence
    [J]. BLOOD, 2012, 120 (21)
  • [50] Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro
    Van Aelst, Britt
    Devloo, Rosalie
    Vandekerckhove, Philippe
    Compernolle, Veerle
    Feys, Hendrik B.
    [J]. TRANSFUSION, 2015, 55 (10) : 2404 - 2414